Mercer Global Advisors Inc. ADV Acquires Shares of 1,941 Balchem Co. (NASDAQ:BCPC)

Mercer Global Advisors Inc. ADV bought a new position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,941 shares of the basic materials company's stock, valued at approximately $316,000.

Several other large investors have also recently made changes to their positions in the stock. Covestor Ltd lifted its holdings in shares of Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares during the period. R Squared Ltd purchased a new position in Balchem in the fourth quarter valued at $29,000. Federated Hermes Inc. purchased a new position in shares of Balchem in the 4th quarter valued at about $33,000. Venturi Wealth Management LLC purchased a new position in Balchem during the fourth quarter worth approximately $95,000. Finally, Smartleaf Asset Management LLC grew its holdings in Balchem by 230.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock valued at $106,000 after purchasing an additional 450 shares during the period. 87.91% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on BCPC shares. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the company a "buy" rating in a report on Monday, April 28th. Sidoti upgraded shares of Balchem to a "hold" rating in a research report on Tuesday, February 25th. Finally, StockNews.com raised shares of Balchem from a "hold" rating to a "buy" rating in a research note on Tuesday, May 13th.

Balchem Trading Up 0.2%

BCPC traded up $0.39 during trading hours on Tuesday, reaching $169.78. The company's stock had a trading volume of 5,608 shares, compared to its average volume of 136,491. Balchem Co. has a fifty-two week low of $145.70 and a fifty-two week high of $186.03. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The stock has a market cap of $5.54 billion, a PE ratio of 43.17, a P/E/G ratio of 4.41 and a beta of 0.93. The business's 50-day moving average is $161.73 and its 200-day moving average is $166.33.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The company had revenue of $250.52 million for the quarter, compared to analysts' expectations of $245.70 million. During the same period in the previous year, the business posted $1.03 EPS. The business's revenue for the quarter was up 4.5% on a year-over-year basis. As a group, equities research analysts predict that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.